Found: 83
Select item for more details and to access through your institution.
Pomalidomide combinations are a safe and effective option after daratumumab failure.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 6569, doi. 10.1007/s00432-023-04637-x
- By:
- Publication type:
- Article
Ex vivo propagation in a novel 3D high-throughput co-culture system for multiple myeloma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 5, p. 1045, doi. 10.1007/s00432-021-03854-6
- By:
- Publication type:
- Article
Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Development of an integrated model of care for allogeneic stem cell transplantation facilitated by eHealth—the SMILe study.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 12, p. 8045, doi. 10.1007/s00520-021-06328-0
- By:
- Publication type:
- Article
Symptom experience of multiple myeloma (syMMex) patients treated with autologous stem cell transplantation following high-dose melphalan: a descriptive longitudinal study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Essential role of stromally induced hedgehog signaling in B-cell malignancies.
- Published in:
- Nature Medicine, 2007, v. 13, n. 8, p. 944, doi. 10.1038/nm1614
- By:
- Publication type:
- Article
Favourable outcomes of double‐hit/double‐expressor lymphoma and high‐grade B‐cell lymphoma, not otherwise specified after early dose‐intensive treatment and up‐front autologous stem cell transplantation: a single‐centre retrospective experience
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 4, p. 776, doi. 10.1111/bjh.18280
- By:
- Publication type:
- Article
Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 3, p. 496, doi. 10.1111/bjh.17338
- By:
- Publication type:
- Article
Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 4, p. 586, doi. 10.1111/bjh.14920
- By:
- Publication type:
- Article
CXCL12 and CXCR7 are relevant targets to reverse cell adhesion-mediated drug resistance in multiple myeloma.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 1, p. 36, doi. 10.1111/bjh.14807
- By:
- Publication type:
- Article
Favourable outcomes of poor prognosis diffuse large B-cell lymphoma patients treated with dose-dense Rituximab, high-dose Methotrexate and six cycles of CHOP-14 compared to first-line autologous transplantation.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 6, p. 927, doi. 10.1111/bjh.14802
- By:
- Publication type:
- Article
From CLL to Multiple Myeloma - Spleen Tyrosine Kinase ( SYK) influences multiple myeloma cell survival and migration.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 6, p. 985, doi. 10.1111/bjh.13825
- By:
- Publication type:
- Article
Clinical phenotype and outcome of persistent SARS-CoV-2 replication in immunocompromised hosts: a retrospective observational study in the Omicron era.
- Published in:
- Infection, 2024, v. 52, n. 3, p. 923, doi. 10.1007/s15010-023-02138-0
- By:
- Publication type:
- Article
COVID-19 pneumonia in a multiple sclerosis patient with severe lymphopenia due to recent cladribine treatment.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 10, p. 1264, doi. 10.1177/1352458520943783
- By:
- Publication type:
- Article
The Asyut Project: Fourteenth and Fifteenth Season of Fieldwork (2018–2019).
- Published in:
- Studien zur Altägyptischen Kultur (SAK), 2021, v. 50, p. 207
- By:
- Publication type:
- Article
Intratibial Injection of Human Multiple Myeloma Cells in NOD/SCID IL-2Rγ(Null) Mice Mimics Human Myeloma and Serves as a Valuable Tool for the Development of Anticancer Strategies.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0079939
- By:
- Publication type:
- Article
The 3' Untranslated Region of the Cyclin B mRNA Is Not Sufficient to Enhance the Synthesis of Cyclin B during a Mitotic Block in Human Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0074379
- By:
- Publication type:
- Article
Ordering Errors Were Identified.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Nephrotoxic Chemotherapy.
- Published in:
- Deutsches Ärzteblatt International, 2010, v. 107, n. 23, p. 1
- By:
- Publication type:
- Article
Safe and successful teclistamab treatment in very elderly multiple myeloma (MM) patients: a case report and experience from a total of three octogenarians.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 12, p. 3639, doi. 10.1007/s00277-023-05451-8
- By:
- Publication type:
- Article
Safe and successful CAR T-cell therapy targeting BCMA in a multiple myeloma patient requiring hemodialysis.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 5, p. 1269, doi. 10.1007/s00277-023-05163-z
- By:
- Publication type:
- Article
Multidisciplinary tumor board analysis: validation study of a central tool in tumor centers.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 603, doi. 10.1007/s00277-022-05051-y
- By:
- Publication type:
- Article
Long-term complete remission of refractory severe idiopathic immune thrombocytopenia (ITP) treated with daratumumab.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 1, p. 245, doi. 10.1007/s00277-022-05035-y
- By:
- Publication type:
- Article
Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumab.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Diffuse large B cell lymphoma (DLBCL): bilateral vanishing tibiae.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Analysis of survival by tumor response: have we learnt any better?
- Published in:
- 2015
- By:
- Publication type:
- Letter
Treatment option of bendamustine in combination with rituximab in elderly and frail patients with aggressive B-non-Hodgkin lymphoma: rational, efficacy, and tolerance.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 10, p. 1579, doi. 10.1007/s00277-012-1503-5
- By:
- Publication type:
- Article
Stevens-Johnson/toxic epidermal necrolysis overlap syndrome following lenalidomide treatment for multiple myeloma relapse after allogeneic transplantation.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Dynamic prediction: A challenge for biostatisticians, but greatly needed by patients, physicians and the public.
- Published in:
- Biometrical Journal, 2020, v. 62, n. 3, p. 822, doi. 10.1002/bimj.201800248
- By:
- Publication type:
- Article
Allogeneic Stem Cell Transplantation in Multiple Myeloma.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 55, doi. 10.3390/cancers14010055
- By:
- Publication type:
- Article
Choosing the Right Therapy for Patients with Relapsed/Refractory Multiple Myeloma (RRMM) in Consideration of Patient-, Disease- and Treatment-Related Factors.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4320, doi. 10.3390/cancers13174320
- By:
- Publication type:
- Article
Kinetics of Renal Function during Induction in Newly Diagnosed Multiple Myeloma: Results of Two Prospective Studies by the German Myeloma Study Group DSMM.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1322, doi. 10.3390/cancers13061322
- By:
- Publication type:
- Article
Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow‐up subgroup analysis of the BOSTON trial.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 2, p. 242, doi. 10.1111/ejh.14223
- By:
- Publication type:
- Article
Identification of clinical factors impacting outcome in patients undergoing autologous hematopoietic cell transplantation after BEAM and TEAM conditioning.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 3, p. 350, doi. 10.1111/ejh.14118
- By:
- Publication type:
- Article
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide‐pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 1, p. 73, doi. 10.1111/ejh.13706
- By:
- Publication type:
- Article
Full or intensity‐reduced high‐dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 5, p. 529, doi. 10.1111/ejh.13690
- By:
- Publication type:
- Article
Two cases of carfilzomib-induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Covid‐19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 22, p. 8412, doi. 10.1002/cam4.3460
- By:
- Publication type:
- Article
Ten Color Multiparameter Flow Cytometry in Bone Marrow and Apheresis Products for Assessment and Outcome Prediction in Multiple Myeloma Patients.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.708231
- By:
- Publication type:
- Article
Multiple myeloma and second malignancies.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Validation of the Freiburg Comorbidity Index in 466 Multiple Myeloma Patients and Combination With the International Staging System Are Highly Predictive for Outcome.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 5, p. 541, doi. 10.1016/j.clml.2013.03.013
- By:
- Publication type:
- Article
Prognostic Risk Factor Evaluation in Patients With Relapsed or Refractory Multiple Myeloma Receiving Lenalidomide Treatment: Analysis of Renal Function by eGFR and of Additional Comorbidities by Comorbidity Appraisal.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2012, v. 12, n. 1, p. 38, doi. 10.1016/j.clml.2011.09.216
- By:
- Publication type:
- Article
Management of multiple myeloma in pregnancy: strategies for a rare challenge.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Management of Multiple Myeloma in Pregnancy: Strategies for a Rare Challenge.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 2, p. 190, doi. 10.1016/j.clml.2011.03.009
- By:
- Publication type:
- Article
Bortezomib consolidation following autologous transplant in younger and older patients with newly diagnosed multiple myeloma in two phase III trials.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 3, p. 255, doi. 10.1111/ejh.13281
- By:
- Publication type:
- Article
The serum heavy/light chain immunoassay: A valuable tool for sensitive paraprotein assessment, risk, and disease monitoring in monoclonal gammopathies.
- Published in:
- European Journal of Haematology, 2017, v. 99, n. 5, p. 449, doi. 10.1111/ejh.12958
- By:
- Publication type:
- Article
Detection of renal impairment as one specific comorbidity factor in multiple myeloma: multicenter study in 198 consecutive patients.
- Published in:
- European Journal of Haematology, 2009, v. 83, n. 6, p. 519, doi. 10.1111/j.1600-0609.2009.01318.x
- By:
- Publication type:
- Article
Myelodysplastic syndrome in transformation to acute myeloid leukemia presenting with diabetes insipidus: due to pituitary infiltration association with abnormalities of chromosomes 3 and 7.
- Published in:
- European Journal of Haematology, 2002, v. 69, n. 2, p. 115, doi. 10.1034/j.1600-0609.2002.02763.x
- By:
- Publication type:
- Article
APC/C<sup>Cdh1</sup> regulates the balance between maintenance and differentiation of hematopoietic stem and progenitor cells.
- Published in:
- Cellular & Molecular Life Sciences, 2019, v. 76, n. 2, p. 369, doi. 10.1007/s00018-018-2952-3
- By:
- Publication type:
- Article
Multidisciplinary tumor boards and their analyses: the yin and yang of outcome measures.
- Published in:
- 2021
- By:
- Publication type:
- Letter